PlainRecalls
FDA Drug Moderate Class II Ongoing

Valsartan Tablets USP 80 mg, 90 count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., Dayton, NJ --- NDC 65862-571-90

Reported: March 27, 2019 Initiated: December 31, 2018 #D-1038-2019

Product Description

Valsartan Tablets USP 80 mg, 90 count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., Dayton, NJ --- NDC 65862-571-90

Reason for Recall

GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.

Details

Recalling Firm
Aurobindo Pharma USA Inc.
Units Affected
N/A
Distribution
Product was distributed to major distribution chains throughout the United States.
Location
East Windsor, NJ

Frequently Asked Questions

What product was recalled?
Valsartan Tablets USP 80 mg, 90 count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., Dayton, NJ --- NDC 65862-571-90. Recalled by Aurobindo Pharma USA Inc.. Units affected: N/A.
Why was this product recalled?
GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 27, 2019. Severity: Moderate. Recall number: D-1038-2019.